Royal Bank of Canada’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-14,000
Closed -$239K 6228
2014
Q3
$239K Buy
14,000
+5,000
+56% +$115K ﹤0.01% 4063
2014
Q2
$268K Sell
9,000
-3,410
-27% -$81.8K ﹤0.01% 3950
2014
Q1
$309K Hold
12,410
﹤0.01% 3741
2013
Q4
$357K Buy
+12,410
New +$363K ﹤0.01% 3676
2013
Q3
Sell
-12,410
Closed -$385K 6172
2013
Q2
$385K Buy
+12,410
New +$333K ﹤0.01% 3376

Other funds holding INVA

Royal Bank of Canada's INVA Position: Q1 2026 in Review

Royal Bank of Canada reduced its Innoviva (INVA) stake by 5.8% in Q1 2026, selling an estimated $13.4K and leaving 10,061 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #4617.

Royal Bank of Canada first reported a position in INVA in Q2 2013 and has held it in 52 quarters since. The position peaked at $24.4M in Q2 2025. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Royal Bank of Canada held 10,061 shares of Innoviva worth $235K as of Q1 2026.
  • Royal Bank of Canada sold 623 Innoviva shares in Q1 2026, an estimated $13.4K.
  • Innoviva made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4617 holding.
  • Royal Bank of Canada first reported a position in Innoviva in Q2 2013 and has held it in 52 quarters since.
  • Royal Bank of Canada's Innoviva position peaked at $24.4M in Q2 2025.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.